How to review and plan for the next regulatory cycle of activities

It has come to the end of the year where budgeting and planning are in full force for 2024. In regulatory, we do it via the RPA way which stands for Review, Plan and Act . TRC shall share a short summary on what RPA means : Review Start off with product annual review to […]

11 Dec 2023 |
Pharmaceutical Consulting

Dos and Don’ts in a regulatory consultation meeting

The next step after performing a regulatory intelligence exercise would be followed by an arrangement for a consultation with the regulatory authority. This is common especially for IND application and NDA application in which there may be concerns regarding the documentation requirements or even addressing any critical CMC, pre-clinical and clinical study related questions. Today […]

20 Nov 2023 |
Pharmaceutical Consulting

Steps to incorporate new regulation changes in approved marketing authorization (MAs)

Part of our routine activity in regulatory affairs is to stay in touch with the latest updates and happenings with our local authority so that we can interpret the new changes, assess the impact it has on our existing product licenses and implement a strategic plan to incorporate the changes. Today TRC would like to […]

14 Nov 2023 |
Pharmaceutical Consulting

As a regulatory service provider aka consultant, each regulatory consultant has their own unique way of execution of regulatory task especially for regulatory submission. However it would not differ too much from what we are going to share with you. TRC would like to share with potential prospects of how we usually manage regulatory […]

06 Nov 2023 |
Pharma Registration

Black and white masks placed on building steps.

What is a borderline medical device in ASEAN terms and published list for your reference?

This is a rather short article to share about the definition and published list of borderline medical device that might be supportive for your regulatory intelligence exercise. A borderline medical device might have some features of a medical device which is to diagnose ,treat or prevent a symptoms or diseases and possibly contain agent or […]

16 Oct 2023 |
Regulatory Affairs

An introduction to registration requirements of Chinese Proprietary Medicines(CPM) in Singapore

Chinese Proprietary Medicines(中成药产品) refers to finished medicinal product, such as a capsule or tablet, and contains one or more active ingredients from any plant, animal or mineral, or any combination of sources. All the active ingredients must be documented for use in traditional Chinese medicine. Prior to importation and distribution of CPM in Singapore, CPM […]

04 Oct 2023 |
Pharma Registration

News & Articles

Recent Posts

If you have any specific regulatory questions pertaining to entering the Singapore market or require assistance with pharma regulatory services and medical product registration, feel free to reach out. Your success in the pharmaceutical industry starts with us!